Table 3 Saliva Aβ42 levels in patients with AD and control subjects
From: Saliva levels of Abeta1-42 as potential biomarker of Alzheimer's disease: a pilot study
Group | No. Of subjects | Age | Aβ42 (pg/ml) |
|---|---|---|---|
AD patients | 38 | Â | Â |
   With Apo E ε4 | 18 | 75.18 ± 7.91 | 6.42 ± 15.48 |
   Without Apo E ε4 | 20 | 75.05 ± 8.85 | 12.52 ± 33.58 |
Control subjects | 34 | Â | Â |
   With Apo E ε4 | 4 | 68.5 ± 8.70 | 2.05 ± 1.48 |
   Without Apo E ε4 | 30 | 69.10 ± 9.25 | 2.51 ± 2.61 |